Literature DB >> 11513477

Changes in kynurenic, anthranilic, and quinolinic acid concentrations in rat brain tissue during development.

G Cannazza1, A Chiarugi, C Parenti, P Zanoli, M Baraldi.   

Abstract

Kynurenic, anthranilic, and quinolinic acid, brain tissue concentrations and indoleamine 2,3-dioxygenase [EC 1 13.11.17] activity were determined in rat brain, during pre- and postnatal development. Quinolinic acid brain tissue concentration was significantly increased at birth as compared with the prenatal level, then it declined rapidly in the postnatal period. By the contrary, kynurenic and anthranilic acids brain tissue concentrations in rat brain were significantly lower at birth as compared with those found prenatally; then kynurenic acid concentration decreased in the first postnatal week and increased thereafter, while anthranilic acid concentration increased in the first postnatal week and decreased thereafter. Indoleamine 2,3-dioxygenase [EC 1 13.11.17] activity were found unchanged in pre and post natal rat brain. The described opposite changes in quinolinic and kynurenic acids concentrations, occurring in pre- and postnatal period, despite the lack of knowledge on the precise role played by these compounds on the different neurotransmitter systems in the brain, could be involved in brain ontogenetic development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11513477     DOI: 10.1023/a:1010960812204

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  15 in total

1.  Effects of mitochondria and o-methoxybenzoylalanine on 3-hydroxyanthranilic acid dioxygenase activity and quinolinic acid synthesis.

Authors:  A Chiarugi; F Moroni
Journal:  J Neurochem       Date:  1999-03       Impact factor: 5.372

Review 2.  Physiological and pathophysiological roles of excitatory amino acids during central nervous system development.

Authors:  J W McDonald; M V Johnston
Journal:  Brain Res Brain Res Rev       Date:  1990 Jan-Apr

3.  Indoleamine 2,3-dioxygenase.

Authors:  R Yoshida; O Hayaishi
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

4.  A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists.

Authors:  M Kessler; T Terramani; G Lynch; M Baudry
Journal:  J Neurochem       Date:  1989-04       Impact factor: 5.372

5.  Structure-activity relationships for amino acid transmitter candidates acting at N-methyl-D-aspartate and quisqualate receptors.

Authors:  D K Patneau; M L Mayer
Journal:  J Neurosci       Date:  1990-07       Impact factor: 6.167

6.  Kynurenine 3-hydroxylase inhibition in rats: effects on extracellular kynurenic acid concentration and N-methyl-D-aspartate-induced depolarisation in the striatum.

Authors:  J Urenjak; T P Obrenovitch
Journal:  J Neurochem       Date:  2000-12       Impact factor: 5.372

7.  Quinolinic acid promotes the biochemical differentiation of cerebellar granule neurons.

Authors:  A Hunt; A J Patel
Journal:  Neurosci Lett       Date:  1990-07-31       Impact factor: 3.046

8.  Developmental changes in brain kynurenic acid concentrations.

Authors:  M F Beal; K J Swartz; O Isacson
Journal:  Brain Res Dev Brain Res       Date:  1992-07-24

9.  Identification of tryptophan 2,3-dioxygenase RNA in rodent brain.

Authors:  R Haber; D Bessette; B Hulihan-Giblin; M J Durcan; D Goldman
Journal:  J Neurochem       Date:  1993-03       Impact factor: 5.372

Review 10.  Neuropharmacology of quinolinic and kynurenic acids.

Authors:  T W Stone
Journal:  Pharmacol Rev       Date:  1993-09       Impact factor: 25.468

View more
  8 in total

1.  Assessment of Prenatal Kynurenine Metabolism Using Tissue Slices: Focus on the Neosynthesis of Kynurenic Acid in Mice.

Authors:  Francesca M Notarangelo; Sarah Beggiato; Robert Schwarcz
Journal:  Dev Neurosci       Date:  2019-05-22       Impact factor: 2.984

2.  Elevated levels of kynurenic acid during gestation produce neurochemical, morphological, and cognitive deficits in adulthood: implications for schizophrenia.

Authors:  Michelle L Pershing; David M Bortz; Ana Pocivavsek; Peter J Fredericks; Christinna V Jørgensen; Sarah A Vunck; Benedetta Leuner; Robert Schwarcz; John P Bruno
Journal:  Neuropharmacology       Date:  2014-11-01       Impact factor: 5.250

Review 3.  Elevated kynurenine pathway metabolism during neurodevelopment: Implications for brain and behavior.

Authors:  Francesca M Notarangelo; Ana Pocivavsek
Journal:  Neuropharmacology       Date:  2016-03-02       Impact factor: 5.250

4.  Targeted deletion of kynurenine 3-monooxygenase in mice: a new tool for studying kynurenine pathway metabolism in periphery and brain.

Authors:  Flaviano Giorgini; Shao-Yi Huang; Korrapati V Sathyasaikumar; Francesca M Notarangelo; Marian A R Thomas; Margarita Tararina; Hui-Qiu Wu; Robert Schwarcz; Paul J Muchowski
Journal:  J Biol Chem       Date:  2013-11-04       Impact factor: 5.157

5.  Acute sleep deprivation during pregnancy in rats: Rapid elevation of placental and fetal inflammation and kynurenic acid.

Authors:  Annalisa M Baratta; Nickole R Kanyuch; Casey A Cole; Homayoun Valafar; Jessica Deslauriers; Ana Pocivavsek
Journal:  Neurobiol Stress       Date:  2019-12-14

6.  A single prenatal lipopolysaccharide injection has acute, but not long-lasting, effects on cerebral kynurenine pathway metabolism in mice.

Authors:  Francesca M Notarangelo; Robert Schwarcz
Journal:  Eur J Neurosci       Date:  2021-08-17       Impact factor: 3.698

Review 7.  Kynurenic Acid in the digestive system-new facts, new challenges.

Authors:  Michal P Turski; Monika Turska; Piotr Paluszkiewicz; Jolanta Parada-Turska; Gregory F Oxenkrug
Journal:  Int J Tryptophan Res       Date:  2013-09-04

8.  Kynurenine pathway metabolism following prenatal KMO inhibition and in Mecp2+/- mice, using liquid chromatography-tandem mass spectrometry.

Authors:  Caroline M Forrest; Peter G E Kennedy; Jean Rodgers; R Neil Dalton; Charles Turner; L Gail Darlington; Stuart R Cobb; Trevor W Stone
Journal:  Neurochem Int       Date:  2016-09-10       Impact factor: 3.921

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.